Suppr超能文献

与系统O血清分型相关的计算机专家系统在医院获得性感染暴发早期检测及铜绿假单胞菌感染经验性抗生素治疗中的应用价值。

Usefulness of a computerized expert system associated with systematic O-serotyping for the early detection of outbreaks of hospital acquired infections and for the presumptive antibiotic therapy of Pseudomonas aeruginosa infections.

作者信息

Watine J, Charet J C, Bruel A, Bouilloux J P, Palliez J

机构信息

Laboratory of Clinical Biology, Centre Hospitalier Général, Rodez, France.

出版信息

Pathol Biol (Paris). 1996 Feb;44(2):125-31.

PMID:8761597
Abstract

Over a four-year period, the systematic O-serotyping of all Pseudomonas aeruginosa isolated in Hôpital de Rodez associated with the use of a computerized expert system, facilitated the early detection of two outbreaks of nosocomial infections with multiresistant serotype O:11 and multiresistant serotype O:12 P. aeruginosa respectively involving ten patients over 16 months and six patients over six months. Over this four-year period, serotype O:12 represented 14% of 404 clinical isolates of P. aeruginosa, and most isolates of this serotype were resistant to multiple antibiotics. Combination experiments showed that fosfomycin/amikacin together were active against 86% of O:12 isolates. Fosfomycin/amikacin might be considered as a therapeutic alternative to ceftazime/amikacin for the presumptive antipseudomonal therapy of serotype O:12 infections.

摘要

在四年时间里,罗德兹医院对所有分离出的铜绿假单胞菌进行系统的O血清型分型,并使用计算机专家系统,这有助于早期发现两起医院感染暴发,分别是多重耐药血清型O:11和多重耐药血清型O:12的铜绿假单胞菌感染,在16个月内涉及10名患者,在6个月内涉及6名患者。在这四年期间,血清型O:12占404株铜绿假单胞菌临床分离株的14%,该血清型的大多数分离株对多种抗生素耐药。联合实验表明,磷霉素/阿米卡星联合使用对86%的O:12分离株有活性。对于血清型O:12感染的推定抗假单胞菌治疗,磷霉素/阿米卡星可被视为头孢他啶/阿米卡星的治疗替代方案。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验